Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Variation in Serial TCD Velocity Measurements in the TCD with Transfusions Changing to Hydroxyurea (TWiTCH) Trial

Russell E. Ware, MD PhD, Adam Lane, PhD, William H Schultz, MHS PA, Hamayun Imran, MD, Margaret T. Lee, MD, Matthew M Heeney, MD, Clark Brown, MD PhD, Lori Luchtman-Jones, MD, Jennifer Webb, MD, Sherron Jackson, MD, Banu Aygun, MD, Scott T. Miller, MD, Jennifer A Rothman, MD, Alexis A. Thompson, MD MPH, Judy Luden, CCRP, Barry R Davis, MD PhD, Robert J. Adams, MD

Blood (2016) 128 (22): 1019.

https://doi.org/10.1182/blood.V128.22.1019.1019

Published: 2016

Journal Articles

TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia

Russell E. Ware, MD PhD, Barry R Davis, MD PhD, William H Schultz, MHS PA, Clark Brown, MD PhD, Banu Aygun, MD, Sharada A. Sarnaik, MD, Isaac Odame, MD, Beng Fuh, MD, Alex George, MD, PhD, William Owen, MD, Lori Luchtman-Jones, MD, Zora R. Rogers, MD, Lee Hilliard, MD, Cynthia Gauger, MD, Connie M. Piccone, MD, Margaret T. Lee, MD, Janet Kwiatkowski, MD, Sherron Jackson, MD, Scott T. Miller, MD, Carla W Roberts, MD, Matthew M. Heeney, MD FRCP(C), Theodosia A. Kalfa, MD PhD, Stephen C Nelson, MD, Hamayun Imran, MD, Kerri A Nottage, MD MPH, Ofelia A. Alvarez, MD, Melissa Rhodes, MD, Alexis A. Thompson, MD, Jennifer Rothman, MD, Kathleen J. Helton, MD, Donna Roberts, MD, Jamie Coleman, MD, Melanie J Bonner, PhD, Abdullah Kutlar, MD, Niren Patel, MD, John C Wood, MD PhD, Linda Piller, MD, Peng Wei, PhD, Judy Luden, CCRP, Nicole A. Mortier, MHS, PA-C, Susan Stuber, MA, Naomi L.C. Luban, MD, Alan R. Cohen, MD, Sara L Pressel, MS, Robert J. Adams, MD MS

Blood (2015) 126 (23): 3.

https://doi.org/10.1182/blood.V126.23.3.3

Published: 2015

Journal Articles

Magnetic Resonance T2* Measurement of Myocardial Iron Deposition in Sickle Cell Disease: Risk Factors and Relationship with Cardiac Function.

Alexander Ngwube, MD, Andrew Hardie, MD, Luis Ramos-Duran, MD, Joseph Schoepf, Ibrahim Shatat, Miguel R. Abboud, MD, Sherron Jackson, Ram Kalpatthi, MD

Blood (2009) 114 (22): 4604.

https://doi.org/10.1182/blood.V114.22.4604.4604

Published: 2009

Journal Articles

Effect of Chronic Blood Transfusions On Progression of Neurovascular Pathology in Pediatric Sickle Cell Patients.

Sarah Bishop, BS, Gisele Matheus, MD, Robert J. Adams, MD, Sherron Jackson, MD, Miguel R. Abboud, MD, Ram Kalpatthi, MD

Blood (2009) 114 (22): 1510.

https://doi.org/10.1182/blood.V114.22.1510.1510

Published: 2009

Journal Articles

Safety and Efficacy of High Dose Intravenous Desferoxamine for Reduction of Iron Overload Due to Chronic Transfusion in Sickle Cell Patients.

Ram Kalpatthi, MD, Brittany Peters, David Holloman, Elizabeth Rackoffe, Deborah Disco, Sherron Jackson, Miguel Abboud, MD

Blood (2008) 112 (11): 1430.

https://doi.org/10.1182/blood.V112.11.1430.1430

Published: 2008

NARROW

Variation in Serial TCD Velocity Measurements in the TCD with Transfusions Changing to Hydroxyurea (TWiTCH) Trial

TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia

Magnetic Resonance T2* Measurement of Myocardial Iron Deposition in Sickle Cell Disease: Risk Factors and Relationship with Cardiac Function.

Effect of Chronic Blood Transfusions On Progression of Neurovascular Pathology in Pediatric Sickle Cell Patients.

Safety and Efficacy of High Dose Intravenous Desferoxamine for Reduction of Iron Overload Due to Chronic Transfusion in Sickle Cell Patients.

Email alerts

ASH Publications

American Society of Hematology

Variation in Serial TCD Velocity Measurements in the TCD with Transfusions Changing to Hydroxyurea (TWiTCH) Trial

TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia

Magnetic Resonance T2* Measurement of Myocardial Iron Deposition in Sickle Cell Disease: Risk Factors and Relationship with Cardiac Function.

Effect of Chronic Blood Transfusions On Progression of Neurovascular Pathology in Pediatric Sickle Cell Patients.

Safety and Efficacy of High Dose Intravenous Desferoxamine for Reduction of Iron Overload Due to Chronic Transfusion in Sickle Cell Patients.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only